Ko F N, Chang Y L, Chen C M, Teng C M
Pharmacological Institute, College of Medicine, National Taiwan University, Taipei.
J Pharm Pharmacol. 1996 Jun;48(6):629-34. doi: 10.1111/j.2042-7158.1996.tb05986.x.
(+/-)-Govadine and (+/-)-THP ((+/-)-2,3,10,11-tetrahydroxytetrahydroprotoberberine HBr) have been shown to inhibit noradrenaline-induced contraction of rat thoracic aortae. The pharmacological activity of the compounds was determined in thoracic aortae and cardiac tissue isolated from the rat and in trachea isolated from the guinea-pig to determine the selectivity of the compounds towards different types of receptor. (+/-)-Govadine and (+/-)-THP were found to be alpha 1-adrenoceptor blocking agents in rat thoracic aorta as revealed by their competitive antagonism of vasoconstriction induced by noradrenaline (pA2 = 6.57 +/- 0.07 and 5.93 +/- 0.06, respectively) or phenylephrine (pA2 = 6.74 +/- 0.08 and 6.06 +/- 0.10, respectively). Removal of endothelium did not affect the antagonistic potencies of (+/-)-govadine (pA2 = 6.83 +/- 0.09) and (+/-)-THP (pA2 = 6.25 +/- 0.06) on phenylephrine-induced vasoconstriction. They were more potent than yohimbine (pA2 = 6.05 +/- 0.05), but less so than phentolamine (pA2 = 7.54 +/- 0.11) and prazosin (pA2 = 9.27 +/- 0.12). (+/-)-Govadine and (+/-)-THP, furthermore, inhibited [3H]inositol monophosphate formation caused by noradrenaline (3 microM) in rat thoracic aorta. (+/-)-Govadine and (+/-)-THP were also alpha 2-adrenoceptor blocking agents with pA2 values 5.50 +/- 0.13 and 5.41 +/- 0.11, respectively. A high concentration of (+/-)-govadine (30 microM) or (+/-)-THP (30 microM) did not, however, affect the contraction induced by the thromboxane receptor agonist U46619, prostaglandin F2 alpha (PGF2 alpha), 5-hydroxytryptamine (5-HT), angiotensin II, endothelin or high K+ in rat aorta denuded of endothelium. Neither the cyclic AMP nor cyclic GMP content of rat thoracic aorta was, furthermore, changed by (+/-)-govadine or (+/-)-THP. Contraction of guinea-pig trachea caused by carbachol, histamine, leukotriene C4 or neurokinin A was not affected by (+/-)-govadine or (+/-)-THP. (+/-)-Govadine or (+/-)-THP also did not block beta 1- or beta 2-adrenoceptor-mediated responses induced by isoprenaline in rat right atria and guinea-pig trachea. It is concluded that (+/-)-govadine and (+/-)-THP are selective alpha 1-adrenoceptor antagonists in vascular smooth muscle.
(±)-戈瓦定和(±)-四氢小檗碱((±)-2,3,10,11-四羟基四氢原小檗碱氢溴酸盐)已被证明可抑制去甲肾上腺素诱导的大鼠胸主动脉收缩。在从大鼠分离的胸主动脉和心脏组织以及从豚鼠分离的气管中测定了这些化合物的药理活性,以确定化合物对不同类型受体的选择性。发现(±)-戈瓦定和(±)-四氢小檗碱在大鼠胸主动脉中是α1肾上腺素能受体阻断剂,这可通过它们对去甲肾上腺素(pA2分别为6.57±0.07和5.93±0.06)或去氧肾上腺素(pA2分别为6.74±0.08和6.06±0.10)诱导的血管收缩的竞争性拮抗作用来揭示。去除内皮并不影响(±)-戈瓦定(pA2 = 6.83±0.09)和(±)-四氢小檗碱(pA2 = 6.25±0.06)对去氧肾上腺素诱导的血管收缩的拮抗效力。它们比育亨宾(pA2 = 6.05±0.05)更有效,但比酚妥拉明(pA2 = 7.54±0.11)和哌唑嗪(pA2 = 9.27±0.12)效力稍弱。此外,(±)-戈瓦定和(±)-四氢小檗碱抑制了大鼠胸主动脉中由去甲肾上腺素(3μM)引起的[3H]肌醇单磷酸形成。(±)-戈瓦定和(±)-四氢小檗碱也是α2肾上腺素能受体阻断剂,pA2值分别为5.50±0.13和5.41±0.11。然而,高浓度的(±)-戈瓦定(30μM)或(±)-四氢小檗碱(30μM)并不影响血栓素受体激动剂U46619、前列腺素F2α(PGF2α)、5-羟色胺(5-HT)、血管紧张素II、内皮素或高钾在去内皮大鼠主动脉中诱导的收缩。此外,(±)-戈瓦定或(±)-四氢小檗碱均未改变大鼠胸主动脉中的环磷酸腺苷或环磷酸鸟苷含量。卡巴胆碱、组胺、白三烯C4或神经激肽A引起的豚鼠气管收缩不受(±)-戈瓦定或(±)-四氢小檗碱影响。(±)-戈瓦定或(±)-四氢小檗碱也不阻断异丙肾上腺素在大鼠右心房和豚鼠气管中诱导的β1或β2肾上腺素能受体介导的反应。结论是,(±)-戈瓦定和(±)-四氢小檗碱是血管平滑肌中的选择性α1肾上腺素能受体拮抗剂。